Jbf Capital, Inc. Brickell Biotech, Inc. Transaction History

Jbf Capital, Inc.

  • $630 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
N/A
295,000 New
295,000 $519,000

Others Institutions Holding BBI

# of Institutions
1
Shares Held
65K
Call Options Held
0
Put Options Held
0
View Full List

About Brickell Biotech, Inc.

BBI Quotes by TradingView
  • Ticker BBI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,873,960
  • Market Cap $6.75M
  • Description
  • Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary ...
More about BBI
Track This Portfolio

Track Jbf Capital, Inc. Portfolio

Follow Jbf Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jbf Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jbf Capital, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email